Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014:2014:750860.
doi: 10.1155/2014/750860. Epub 2014 Mar 4.

Early effects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individuals

Affiliations

Early effects of a hypocaloric, Mediterranean diet on laboratory parameters in obese individuals

Marta Greco et al. Mediators Inflamm. 2014.

Abstract

Calorie restriction is a common strategy for weight loss in obese individuals. However, little is known about the impact of moderate hypocaloric diets on obesity-related laboratory parameters in a short-term period. Aim of this study was to evaluate the variation of laboratory biomarkers in obese individuals following a Mediterranean, hypocaloric (1400-1600 Kcal/die) diet. 23 obese, pharmacologically untreated patients were enrolled and subjected to the determination of anthropometric variables and blood collection at baseline, 1 and 4 months after diet initiation. After 4 months of calorie restriction, we observed a significant decrease in body weight and BMI (both P < 0.0001), insulin (P = 0.037), HOMA-IR (P = 0.026), leptin (P = 0.008), and LDH (P = 0.023) and an increase in EGF (P = 0.013). All these parameters, except LDH, varied significantly already at 1 month after diet initiation. Also, lower levels of insulin (P = 0.025), leptin (P = 0.023), and EGF (P = 0.035) were associated with a greater (>5%) weight loss. Collectively, our data support a precocious improvement of insulin and leptin sensitivity after a modest calorie restriction and weight reduction. Moreover, EGF and LDH may represent novel markers of obesity, which deserve further investigations.

PubMed Disclaimer

References

    1. World Health Organization. WHO Technical Report. 894. Geneva. Switzerland: World Health Organization; 2000. Obesity: preventing and managing the global epidemic. - PubMed
    1. Ogden CL, Lamb MM, Carroll MD, Flegal KM. Prevalence of Obesity in the United States, 2009-2010. NCHS Data Brief. 2012;82:1–8. - PubMed
    1. Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007-2008. Journal of the American Medical Association. 2010;303(3):242–249. - PubMed
    1. Vasan RS, Pencina MJ, Cobain M, Freiberg MS, D’Agostino RB. Estimated risks for developing obesity in the Framingham Heart Study. Annals of Internal Medicine. 2005;143(7):473–I12. - PubMed
    1. Klein S, Burke LE, Bray GA, et al. Clinical implications of obesity with specific focus on cardiovascular disease: a statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2004;110(18):2952–2967. - PubMed

LinkOut - more resources